Emperra's digital diabetes management solution ESYSTA now on prescription

Potsdam, Germany

Emperra GmbH E-Health Technologies is proud to announce that their digital diabetes management solution ESYSTA is now officially approved by the German Federal Institutes for Drugs and Medical Devices (BfArM).
More than 3.5 million diabetic patients using insulin and their health care professionals are now able to use ESYSTA on prescription to improve communication and help patients in their daily diabetes management.
Thanks to the entire Emperra GmbH E-Health Technologies Team for your extraordinary efforts to reach this milestone!
Thanks as well in our investors which helped to make this cornerstone achievement to become true.


About the EYEMATE™ System

ESYSTA is managing your diabetes diary: Fully automatic transmission of data from the blood glucose meter and insulin pens using GSM and Bluetooth wireless technology.

About Emperra GmbH E-Health Technologies

Emperra GmbH E-Health Technologies offers a unique, holistic, state of the art, proven and AI enabled Diabetes Management solution to help people with diabetes to get in control of their metabolic conditions, help healthcare professionals in their daily practice and, as a positive consequence, save money for payers and societies by healthier people with diabetes and more productivity in the treatment process.


Emperra GmbH E-Health Technologies
+49 (0) 331 979 3480-0

Go back